semaglutide adverse effects icd 10 New Side of (Ozempic & Wegovy): Symptoms, Risks and Safety Full article: Impact of semaglutide

Most Common Side Effects: Just like other GLP-1 medications, gastrointestinal issues were the most common: Nausea (especially during dose increases) Diarrhea Vomiting Constipation Abdominal pain The frequency: Higher with 8 mg and 12 mg doses compared to lower doses

Equally importantly, GLP-1 receptor agonist use was associated with some increased risks compared to usual care with other treatments

They may suggest lowering the Wegovy dose or pausing treatment

A withdrawn nomination cannot sit in Category 2

For longer-term research, intermittent dosing schedules may be more practical, with adjustments to the dose amount per administration to achieve the desired cumulative exposure

CagriSema expands the field beyond GLP-1 alone: Novo Nordisk's cagrilintide/semaglutide combination pairs an amylin analog with a GLP-1 receptor agonist